Pelikan closes $25M for handheld diagnostics
Pelikan Technologies, maker of medical devices for diagnosing and monitoring diabetes, just brought in $25 million from undiclosed investors, reports VentureWire. Based in Palo Alto, Calif., the company spun out of Agilent Technologies in 2001 with the launch of its Pelikan Sun line, an electronic lancing device used to test blood sugar.
This round of capital brings its total raised to $145 million (it last raised $89 million at the end of 2007). Past investors (that may or may not have contributed to the recent investment) include Bio*One Capital, Clarus Ventures, GE Finance, Global Life Science Ventures, HBM BioVentures, Mannheim Holdings and Oxford Finance.
Next Story: Aptera sets October delivery date for three-wheeled electric vehicle
Previous Story: Neuralitic pulls in $3M for data service analytics
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.